HSR24-160: Immune Checkpoint Inhibitor-Induced Type 1 Diabetes Mellitus: Patient Characteristics, Clinical Outcomes, and Survival Implications of Autoantibodies

Authors:
John Sharp The Ohio State University James Cancer Hospital and Solove Research Institute, Columbus, OH

Search for other papers by John Sharp in
Current site
Google Scholar
PubMed
Close
 MD
,
Cassandra Pasadyn The Ohio State University James Cancer Hospital and Solove Research Institute, Columbus, OH

Search for other papers by Cassandra Pasadyn in
Current site
Google Scholar
PubMed
Close
 AB
,
Songzhu Zhao The Ohio State University James Cancer Hospital and Solove Research Institute, Columbus, OH

Search for other papers by Songzhu Zhao in
Current site
Google Scholar
PubMed
Close
 MS
,
Lai Wei The Ohio State University James Cancer Hospital and Solove Research Institute, Columbus, OH

Search for other papers by Lai Wei in
Current site
Google Scholar
PubMed
Close
 PhD
,
Carolyn Presley The Ohio State University James Cancer Hospital and Solove Research Institute, Columbus, OH

Search for other papers by Carolyn Presley in
Current site
Google Scholar
PubMed
Close
 MD
,
Dwight Owen The Ohio State University James Cancer Hospital and Solove Research Institute, Columbus, OH

Search for other papers by Dwight Owen in
Current site
Google Scholar
PubMed
Close
 MD, MS
,
Kathleen Wyne The Ohio State University James Cancer Hospital and Solove Research Institute, Columbus, OH

Search for other papers by Kathleen Wyne in
Current site
Google Scholar
PubMed
Close
 MD, PhD
, and
Alexa Meara The Ohio State University James Cancer Hospital and Solove Research Institute, Columbus, OH

Search for other papers by Alexa Meara in
Current site
Google Scholar
PubMed
Close
 MD
Restricted access

Corresponding Author: John Sharp, MD
  • Collapse
  • Expand
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 248 248 22
PDF Downloads 121 121 0
EPUB Downloads 0 0 0